{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:30:49Z","timestamp":1787772649161,"version":"build-2784847793"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,26]]},"DOI":"10.7759\/cureus.115246","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:07:30Z","timestamp":1787771250000},"source":"Crossref","is-referenced-by-count":0,"title":["Hyperemesis Gravidarum and the Genetics of Growth Differentiation Factor 15 (GDF-15): A Case Report"],"prefix":"10.7759","author":[{"given":"Ana","family":"Alfaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailee","family":"Myxter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lacey","family":"Vaile-Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica E","family":"Pullan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00737-016-0707-4","article-title":"Treatment options for hyperemesis gravidarum","volume":"20","author":"Abramowitz A","year":"2017","unstructured":"Abramowitz A, Miller ES, Wisner KL. Treatment options for hyperemesis gravidarum. Arch Womens Ment Health. 2017, 20:363-72. 10.1007\/s00737-016-0707-4","journal-title":"Arch Womens Ment Health"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-022-04922-6","article-title":"Assessment of management approaches for hyperemesis gravidarum and nausea and vomiting of pregnancy: a retrospective questionnaire analysis","volume":"22","author":"Mares R","year":"2022","unstructured":"Mares R, Morrow A, Shumway H, Zapata I, Forstein D, Brooks B. Assessment of management approaches for hyperemesis gravidarum and nausea and vomiting of pregnancy: a retrospective questionnaire analysis. BMC Pregnancy Childbirth. 2022, 22:609. 10.1186\/s12884-022-04922-6","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref3","article-title":"Understanding hyperemesis gravidarum","volume":"60","author":"Loh KY","year":"2005","unstructured":"Loh KY, Sivalingam N. Understanding hyperemesis gravidarum. Med J Malaysia. 2005, 60:394-9.","journal-title":"Med J Malaysia"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-052687","article-title":"Systematic evidence map of evidence addressing the top 10 priority research questions for hyperemesis gravidarum","volume":"12","author":"Dean CR","year":"2022","unstructured":"Dean CR, Nijsten K, Spijker R, O'Hara M, Roseboom TJ, Painter RC. Systematic evidence map of evidence addressing the top 10 priority research questions for hyperemesis gravidarum. BMJ Open. 2022, 12:052687. 10.1136\/bmjopen-2021-052687","journal-title":"BMJ Open"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/medsci13030132","article-title":"Hyperemesis in pregnancy: complications and treatment","volume":"13","author":"Gerede A","year":"2025","unstructured":"Gerede A, Stavros S, Moustakli E, et al.. Hyperemesis in pregnancy: complications and treatment. Med Sci (Basel). 2025, 13:132. 10.3390\/medsci13030132","journal-title":"Med Sci (Basel)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0110-3","article-title":"Nausea and vomiting of pregnancy and hyperemesis gravidarum","volume":"5","author":"Fejzo MS","year":"2019","unstructured":"Fejzo MS, Trovik J, Grooten IJ, et al.. Nausea and vomiting of pregnancy and hyperemesis gravidarum. Nat Rev Dis Primers. 2019, 5:62. 10.1038\/s41572-019-0110-3","journal-title":"Nat Rev Dis Primers"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00951","article-title":"Growth\/differentiation factor-15 (GDF-15): from biomarker to novel targetable immune checkpoint","volume":"11","author":"Wischhusen J","year":"2020","unstructured":"Wischhusen J, Melero I, Fridman WH. Growth\/differentiation factor-15 (GDF-15): from biomarker to novel targetable immune checkpoint. Front Immunol. 2020, 11:951. 10.3389\/fimmu.2020.00951","journal-title":"Front Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1101\/2023.06.02.542661","article-title":"Fetally-encoded GDF15 and maternal GDF15 sensitivity are major determinants of nausea and vomiting in human pregnancy (Preprint)","author":"Fejzo M","year":"2023","unstructured":"Fejzo M, Rocha N, Cimino I, et al.. Fetally-encoded GDF15 and maternal GDF15 sensitivity are major determinants of nausea and vomiting in human pregnancy (Preprint). bioRxiv. 2023, 10.1101\/2023.06.02.542661","journal-title":"bioRxiv"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.17129","article-title":"Whole-exome sequencing uncovers new variants in GDF15 associated with hyperemesis gravidarum","volume":"129","author":"Fejzo MS","year":"2022","unstructured":"Fejzo MS, MacGibbon KW, First O, Quan C, Mullin PM. Whole-exome sequencing uncovers new variants in GDF15 associated with hyperemesis gravidarum. BJOG. 2022, 129:1845-52. 10.1111\/1471-0528.17129","journal-title":"BJOG"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03258-0","article-title":"Placenta and appetite genes GDF15 and IGFBP7 are associated with hyperemesis gravidarum","volume":"9","author":"Fejzo MS","year":"2018","unstructured":"Fejzo MS, Sazonova OV, Sathirapongsasuti JF, et al.. Placenta and appetite genes GDF15 and IGFBP7 are associated with hyperemesis gravidarum. Nat Commun. 2018, 9:1178. 10.1038\/s41467-018-03258-0","journal-title":"Nat Commun"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2020.10.004","article-title":"Insights into mechanisms of GDF15 and receptor GFRAL: therapeutic targets","volume":"31","author":"Rochette L","year":"2020","unstructured":"Rochette L, Zeller M, Cottin Y, Vergely C. Insights into mechanisms of GDF15 and receptor GFRAL: therapeutic targets. Trends Endocrinol Metab. 2020, 31:939-51. 10.1016\/j.tem.2020.10.004","journal-title":"Trends Endocrinol Metab"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06921-9","article-title":"GDF15 linked to maternal risk of nausea and vomiting during pregnancy","volume":"625","author":"Fejzo M","year":"2024","unstructured":"Fejzo M, Rocha N, Cimino I, et al.. GDF15 linked to maternal risk of nausea and vomiting during pregnancy. Nature. 2024, 625:760-7. 10.1038\/s41586-023-06921-9","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2021.09.004","article-title":"The windsor definition for hyperemesis gravidarum: a multistakeholder international consensus definition","volume":"266","author":"Jansen LA","year":"2021","unstructured":"Jansen LA, Koot MH, Van't Hooft J, et al.. The windsor definition for hyperemesis gravidarum: a multistakeholder international consensus definition. Eur J Obstet Gynecol Reprod Biol. 2021, 266:15-22. 10.1016\/j.ejogrb.2021.09.004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1159\/000477853","article-title":"Hyperemesis gravidarum: a review of recent literature","volume":"100","author":"London V","year":"2017","unstructured":"London V, Grube S, Sherer DM, Abulafia O. Hyperemesis gravidarum: a review of recent literature. Pharmacology. 2017, 100:161-71. 10.1159\/000477853","journal-title":"Pharmacology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/medicines11070017","article-title":"GDF15 Targeting for Treatment of Hyperemesis Gravidarum","volume":"11","author":"Thygerson J","year":"2024","unstructured":"Thygerson J, Oyler D, Thomas J, Muse B, Brooks BD, Pullan JE. GDF15 Targeting for Treatment of Hyperemesis Gravidarum. Medicines (Basel). 2024, 11:17. 10.3390\/medicines11070017","journal-title":"Medicines (Basel)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107902","article-title":"GDF15 deficiency hinders human trophoblast invasion to mediate pregnancy loss through downregulating Smad1\/5 phosphorylation","volume":"26","author":"Zeng YT","year":"2023","unstructured":"Zeng YT, Liu WF, Zheng PS, Li S. GDF15 deficiency hinders human trophoblast invasion to mediate pregnancy loss through downregulating Smad1\/5 phosphorylation. iScience. 2023, 26:107902. 10.1016\/j.isci.2023.107902","journal-title":"iScience"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-026-02564-4","article-title":"Multi-ancestry genome-wide association study of severe pregnancy nausea and vomiting","volume":"58","author":"Fejzo M","year":"2026","unstructured":"Fejzo M, Wang X, Tan Q, et al.. Multi-ancestry genome-wide association study of severe pregnancy nausea and vomiting. Nat Genet. 2026, 58:810-20. 10.1038\/s41588-026-02564-4","journal-title":"Nat Genet"},{"key":"ref18","unstructured":"A research study testing NGM120 in pregnant women with severe nausea and vomiting (hyperemesis gravidarum). (2025). Accessed. June 18, 2025: https:\/\/www.isrctn.com\/ISRCTN76681798."},{"key":"ref19","unstructured":"Amylyx Pharmaceuticals announces positive topline results from phase 3 lucidity clinical trial of avexitide in post-bariatric hypoglycemia. (2026). https.\/\/www.amylyx.com\/news\/amylyx-pharmaceuticals-announces-positive-topline-results-from-phase-3-lucidity-clinical-...."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0945-x","article-title":"Antibody-mediated inhibition of GDF15-GFRAL activity reverses cancer cachexia in mice","volume":"26","author":"Suriben R","year":"2020","unstructured":"Suriben R, Chen M, Higbee J, et al.. Antibody-mediated inhibition of GDF15-GFRAL activity reverses cancer cachexia in mice. Nat Med. 2020, 26:1264-70. 10.1038\/s41591-020-0945-x","journal-title":"Nat Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/523732-hyperemesis-gravidarum-and-the-genetics-of-growth-differentiation-factor-15-gdf-15-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:07:31Z","timestamp":1787771251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/523732-hyperemesis-gravidarum-and-the-genetics-of-growth-differentiation-factor-15-gdf-15-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.115246","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,26]]}}}